AF

Amreen Fatima

Active Director Director DIN 10512982
DIN 10512982 First appointment Feb 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2024
Shareholding value Locked Premium profile

About Amreen Fatima

Amreen Fatima has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Eironia Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10512982
Primary Designation Director
First Appointment 18 Feb 2024
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Eironia Pharma Private Limited U46497TS2024PTC182305
Director 18 Feb 2024 2024 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eironia Pharma Private Limited
Premium access

Shareholding and investment profile for Amreen Fatima

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amreen Fatima

Amreen Fatima has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Eironia Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Amreen Fatima is associated with 1 company as Director.

Amreen Fatima has expertise in General Business.

Amreen Fatima has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available